Yahoo! Finance Search - Finance Home - Yahoo! - Help

Friday, December 19 2014 5:48pm ET - U.S. Markets Closed.
Industry Center - Drug Delivery
Industry Center > Drug Delivery > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Delivery News
Latest News
Friday, Dec 19, 2014
·InSite Vision Announces Date for Annual Stockholder Meeting
Business Wire - 1 hour, 18 minutes ago
·Flamel Technologies Announces Positive Results of a Second Clinical Trial With Micropump(R) Sodium Oxybate
Marketwire - Fri 8:00 am ET
Wednesday, Dec 17, 2014
·Generex Announces Participation in MedCannAccess┬« - CannScience Partnership on Non-Smoked Forms of Marijuana
PR Newswire - Wed Dec 17
·Generex Announces Participation in MedCannAccess┬« - CannScience Partnership on Non-Smoked Forms of Marijuana
CNW Group - Wed Dec 17
Tuesday, Dec 16, 2014
·Flamel Technologies Transfers Intangible Property to Irish-Based Subsidiary in Global Reorganization
Marketwire - Tue Dec 16
Monday, Dec 15, 2014
·Valeant Pharmaceuticals To Hold Conference Call To Announce 2015 Financial Guidance
PR Newswire - Mon Dec 15
·Valeant Pharmaceuticals To Hold Conference Call To Announce 2015 Financial Guidance
CNW Group - Mon Dec 15
·Flamel Technologies to Be Included in NASDAQ Biotech Index
Marketwire - Mon Dec 15
Thomson Reuters ONE - Mon Dec 15
·Alkermes Announces Initiation of Clinical Study of Extended Durations of Aripiprazole Lauroxil for Treatment of Schizophrenia
Business Wire - Mon Dec 15
Thursday, Dec 11, 2014
Thomson Reuters ONE - Thu Dec 11
Wednesday, Dec 10, 2014
·Herb Greenberg: What's Next for Valeant After Its Botched Bid for Allergan
at - Wed Dec 10
Tuesday, Dec 9, 2014
·Will Valeant Pharmaceuticals (VRX) Stock be Helped Today by New Strategy?
at - Tue Dec 9
Monday, Dec 8, 2014
·Acura Pharmaceuticals Receives Additional U.S. Patent for Abuse Deterrent Drug Formulations
Marketwire - Mon Dec 8
Thursday, Dec 4, 2014
·Why Flamel Technologies (FLML) Could Be Positioned for a Surge? - Thu Dec 4
Wednesday, Dec 3, 2014
·Shareholder Value: The World's Dumbest Idea?
at - Wed Dec 3
·Valeant (VRX) Stock: Moving Average Crossover Alert - Wed Dec 3
Tuesday, Dec 2, 2014
·Adamis Pharmaceuticals to Present at Two Upcoming Conferences
GlobeNewswire - Tue Dec 2
Monday, Dec 1, 2014
·Flamel Technologies Closes Sale of Development and Manufacturing Facility in Pessac, France to Recipharm AB
Marketwire - Mon Dec 1
Friday, Nov 28, 2014
·Valeant Announces Redemption of US$445.0 Million Aggregate Principal Amount of its Outstanding 6.875% Senior Notes due 2018
CNW Group - Fri Nov 28
More Latest News...
Sponsor Results
Biomarker Discovery!
Full service for biomarker discovery. Hundreds of targets analyzed!
United Science QuEChERS
A Better Way to Recover your Planar Pesticides. No Toluene. No kidding.
Proteomic Analysis
2-D LC-MS/MS from $1000 Rapid turn-around, request a quote
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Delivery Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?